Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chen, Tianqi"'
Autor:
Zhou J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Guleria I; Tissue Typing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Chen T; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Giobbie-Hurder A; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Stevens J; Tissue Typing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Gupta M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Wu X; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Brennick RC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. stephen_hodi@dfci.harvard.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Aug; Vol. 68 (8), pp. 1331-1340. Date of Electronic Publication: 2019 Jul 18.
Autor:
Han F; Zhejiang Chinese Medical University, Hangzhou, 310053, China., Xu L; Hangzhou Medical College, Hangzhou, 310053, China., Huang Y; Zhejiang Provincial People's Hospital, Hangzhou, 310014, China., Chen T; People's Hospital of Shaoxing City, Shaoxing, 312000, China., Zhou T; Zhejiang Chinese Medical University, Hangzhou, 310053, China., Yang L; Zhejiang Provincial People's Hospital, Hangzhou, 310014, China. yanglw1967@163.com.
Publikováno v:
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2018 Sep; Vol. 298 (3), pp. 631-638. Date of Electronic Publication: 2018 Jul 23.